018620 — WooGene B&G Co Income Statement

0.000.00%

Last trade - 00:00

HealthcareBalancedMicro CapSucker Stock

Annual income statement for WooGene B&G Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	39,524	39,347	43,703	57,919	55,680
Cost of Revenue
Gross Profit	8,263	8,289	9,471	14,940	16,197
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Total Operating Expenses	38,861	41,879	42,225	57,437	63,687
Operating Profit	664	-2,532	1,478	482	-8,007
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	-737	-396	667	-1,764	-5,756
Provision for Income Taxes
Net Income After Taxes	-1,862	-1,039	1,013	-1,187	-3,830
Minority Interest
Net Income Before Extraordinary Items
Extraordinary Items
Net Income	-2,064	-2,258	850	-1,184	-5,221
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	-2,064	-2,258	850	-1,184	-5,221
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	-105	-15.3	23.1	-36.4	7.63
Dividends per Share